[
  {
      "Company": "Quris-AI",
      "Model": "Liver-on-Chip",
      "Organs/Tissues": "Human liver micro-tissue for drug metabolism and DILI (drug-induced liver injury) prediction",
      "Physiological/Pathological": "Physiological liver function, used to detect pathological toxicity responses",
      "Cell Source": "iPSC-derived hepatocytes (often from diverse donors), potentially co-cultured with non-parenchymal cells",
      "Multiple Cell Types": "Yes, core is hepatocytes; optional Kupffer cells or stellate for advanced function",
      "Stromal Cells": "Yes (stellate) if needed; not always standard",
      "Tissue-resident Immune": "Possible inclusion of Kupffer cells, but not guaranteed",
      "Circulating Immune": "No typical immune circulation in the system",
      "Crosstalk with Other Tissues": "Potentially integrated with other organ chips or AI-simulated crosstalk, physically or via data synergy",
      "Air–Liquid Interface": "No",
      "Extracellular Matrix": "Likely collagen or hydrogel scaffolds in microfluidic wells",
      "3D Scaffold": "Yes (3D hepatic aggregates/organoids in micro-chambers)",
      "Notable Features": "High-throughput microfluidic array with integrated sensors, data feeding Quris Bio-AI for safety predictions",
      "Plate/Format (Throughput)": "Proprietary multi-well microfluidic chip with nano-sensors, thousands of parallel tests possible",
      "Max Culture Duration": "Days to ~2 weeks for repeated dosing or metabolism tests",
      "Readouts - Live Imaging": "Limited; main readouts from integrated nano-sensors, but imaging is possible for deeper analysis",
      "Readouts - Supernatant Sampling": "Yes, to measure secreted markers or drug/metabolites",
      "Readouts - Cell Retrieval": "End-of-run tissue harvest for validation; not routine in high-throughput",
      "Readouts - Whole Tissue": "If needed, can fix the micro-liver tissue for histology or IF",
      "Readouts - TEER": "No (not a barrier), measure viability/toxicity via sensors",
      "Readouts - MEA": "No, not relevant for liver; rely on biosensor + AI approach",
      "Readouts - Integrated Biosensors": "Yes (core feature: real-time sensor data for toxicity signatures)",
      "Dead Volume": "Minimal microliter-scale volume, minimal compound usage",
      "Perfused": "Yes or partial flow; microfluidic format with dynamic fluid control",
      "Gas Mix Controlled": "Incubator environment, automated system ensures standard conditions",
      "Real-time Microenvironment Control": "Automated dosing schedules, sensor-based monitoring in real-time",
      "model_availability": "Not sold; available via Quris’s internal platform or partner collaborations"
    },
    {
      "Company": "Quris-AI",
      "Model": "Heart-on-Chip",
      "Organs/Tissues": "Human cardiac microtissue for cardiotoxicity testing",
      "Physiological/Pathological": "Physiological beating heart muscle; can detect pathological arrhythmias or contractile dysfunction",
      "Cell Source": "iPSC-derived cardiomyocytes (multiple donors for genetic diversity), possibly co-cultured with cardiac fibroblasts",
      "Multiple Cell Types": "Yes (CMs + fibroblasts); no immune or endothelial",
      "Stromal Cells": "Cardiac fibroblasts for structural support",
      "Tissue-resident Immune": "No",
      "Circulating Immune": "No",
      "Crosstalk with Other Tissues": "Potential multi-organ integration or AI-driven crosstalk simulation, not physically linked by default",
      "Air–Liquid Interface": "No (fully submerged beating tissue)",
      "Extracellular Matrix": "3D matrix enabling contractile tissue formation",
      "3D Scaffold": "Yes, 3D beating micro-tissue with integrated sensors for conduction/arrhythmia",
      "Notable Features": "High-throughput sensor-based readouts of contractility & arrhythmias, used by Quris’s AI to predict cardiotoxicity",
      "Plate/Format (Throughput)": "Large array of micro-wells with built-in electrodes or impedance sensors, enabling thousands of parallel tests",
      "Max Culture Duration": "Days to a couple weeks, enough to detect chronic cardiotoxicity",
      "Readouts - Live Imaging": "Possible; main routine from nano-sensors capturing beat patterns",
      "Readouts - Supernatant Sampling": "Yes, if needed (cardiac injury biomarkers, etc.)",
      "Readouts - Cell Retrieval": "Feasible after run, but not typical in high-throughput",
      "Readouts - Whole Tissue": "Possible for endpoint histology if a sample is singled out",
      "Readouts - TEER": "No",
      "Readouts - MEA": "Equivalent functionality (electrical or mechanical sensors) integrated, real-time beat detection",
      "Readouts - Integrated Biosensors": "Yes (core approach: nano-sensing of beat rate, conduction, etc.)",
      "Dead Volume": "Low microfluidic volume",
      "Perfused": "Microfluidic approach or partial flow for nutrient supply; no large external pump needed",
      "Gas Mix Controlled": "Incubator-based environment",
      "Real-time Microenvironment Control": "Automated drug additions & pacing protocols, AI monitoring in real time",
      "model_availability": "Part of Quris’s internal AI-driven service/partnership"
    },
    {
      "Company": "Quris-AI",
      "Model": "Brain-on-Chip",
      "Organs/Tissues": "Human neuronal tissue (iPSC-derived neurons/glia) for neurotoxicity or efficacy testing",
      "Physiological/Pathological": "Physiological baseline neuronal network; can detect excitotoxicity or seizure-like activity",
      "Cell Source": "iPSC-derived neurons, astrocytes, from diverse donors",
      "Multiple Cell Types": "Yes (neurons + astrocytes, possibly other glia)",
      "Stromal Cells": "Astrocytes act as supportive glia; no fibroblasts",
      "Tissue-resident Immune": "No microglia by default",
      "Circulating Immune": "No",
      "Crosstalk with Other Tissues": "Potential linking or AI-based integration with other chips (BBB, etc.)",
      "Air–Liquid Interface": "No",
      "Extracellular Matrix": "Yes, neural cells grown in 3D hydrogel or microfluidic well",
      "3D Scaffold": "Yes, 3D neural cluster with synaptic connectivity",
      "Notable Features": "Continuous sensor readouts of neuronal firing or stress signals, synergy with Quris AI for neuro-safety predictions",
      "Plate/Format (Throughput)": "High-density microfluidic array with embedded neuronal activity sensors",
      "Max Culture Duration": "Days to a couple weeks for neural viability, stable enough to see chronic effects",
      "Readouts - Live Imaging": "Optional but main routine from integrated sensors or calcium imaging",
      "Readouts - Supernatant Sampling": "Yes, for neurotransmitter or secreted factor detection",
      "Readouts - Cell Retrieval": "Possible at endpoint, not typical in large screens",
      "Readouts - Whole Tissue": "Yes if needed for histology",
      "Readouts - TEER": "No (not a barrier epithelium)",
      "Readouts - MEA": "Likely integrated electrode arrays measuring synaptic/electrical activity in real time",
      "Readouts - Integrated Biosensors": "Yes, real-time electrical activity or impedance sensors for neuronal viability/firing",
      "Dead Volume": "Minimal microfluidic volumes",
      "Perfused": "Microfluidic environment or partial flow for long-term culture",
      "Gas Mix Controlled": "Incubator environment",
      "Real-time Microenvironment Control": "Automated dosing & electrical stimulation, AI-driven data capture",
      "model_availability": "Internal Quris platform usage, accessible via collaboration"
    },
    {
      "Company": "Quris-AI",
      "Model": "Blood–Brain Barrier (BBB) Chip",
      "Organs/Tissues": "Human brain microvascular endothelium + astrocytes/pericytes forming BBB",
      "Physiological/Pathological": "Physiological tight junction barrier; can assess pathological disruptions or drug permeability",
      "Cell Source": "iPSC-derived brain endothelial cells, astrocytes, pericytes from diverse donors",
      "Multiple Cell Types": "Yes (endothelium + glia) for functional BBB",
      "Stromal Cells": "Pericytes as supportive cells; astrocytes as glial stroma",
      "Tissue-resident Immune": "No microglia by default",
      "Circulating Immune": "No",
      "Crosstalk with Other Tissues": "Possible link to brain chip or other organ chips via microfluidics or AI-based synergy",
      "Air–Liquid Interface": "No, fully fluid-based barrier system",
      "Extracellular Matrix": "Yes, hydrogel or ECM coatings to support endothelial-glial interface",
      "3D Scaffold": "A 3D arrangement, though can be parallel channels of endothelium plus astrocyte compartment",
      "Notable Features": "Tight junction expression, integrated sensor measuring barrier integrity and drug transport for CNS predictions",
      "Plate/Format (Throughput)": "High-throughput microfluidic array with TEER-like or nano-sensor-based readouts",
      "Max Culture Duration": "Days to ~2 weeks for stable barrier function tests",
      "Readouts - Live Imaging": "Possible for junction staining or tracer leakage, but main routine from sensor data",
      "Readouts - Supernatant Sampling": "Yes, can measure drug crossing or secreted factors on abluminal side",
      "Readouts - Cell Retrieval": "At endpoint for expression analysis, not typical in large screens",
      "Readouts - Whole Tissue": "Yes if needed for IHC of tight junction proteins",
      "Readouts - TEER": "Equivalent built-in sensor measuring barrier resistance in real time",
      "Readouts - MEA": "No (BBB is not excitable tissue)",
      "Readouts - Integrated Biosensors": "Yes, real-time detection of barrier changes, possibly chip-embedded electrodes",
      "Dead Volume": "Very small channels, minimal media usage",
      "Perfused": "Yes, a microchannel with flow simulating blood side, separate brain side",
      "Gas Mix Controlled": "Incubator environment",
      "Real-time Microenvironment Control": "Automated dosing, sensor feedback. AI tracks drug crossing",
      "model_availability": "Internal Quris platform usage via partner projects"
    },
    {
      "Company": "Quris-AI",
      "Model": "Kidney-on-Chip",
      "Organs/Tissues": "Human renal proximal tubule or glomerulus mimic for nephrotoxicity testing",
      "Physiological/Pathological": "Normal kidney filtration and reabsorption, used to detect pathological toxicity or injury",
      "Cell Source": "iPSC-derived kidney epithelial cells, or primary renal tubular cells (from Nortis tech)",
      "Multiple Cell Types": "Yes, tubular epithelial cells ± supporting cells; not typically including immune or endothelium unless specialized",
      "Stromal Cells": "Renal fibroblasts or mesangial cells optional, depending on model specifics",
      "Tissue-resident Immune": "Not standard",
      "Circulating Immune": "No",
      "Crosstalk with Other Tissues": "Possible link to other Quris chips or data-based multi-organ PK modeling",
      "Air–Liquid Interface": "No, fluidic channel simulating renal tubule lumen",
      "Extracellular Matrix": "Yes, collagen or other scaffold forming tubular structure",
      "3D Scaffold": "Yes, microfluidic tubule geometry with epithelial lining",
      "Notable Features": "Predicts nephrotoxicity missed by animals, uses iPSC or primary cells in a microfluidic tubule environment",
      "Plate/Format (Throughput)": "High-throughput microfluidic array licensed from Nortis, integrated into Quris system",
      "Max Culture Duration": "Up to 2 weeks, enough for repeated dosing or chronic kidney toxicity",
      "Readouts - Live Imaging": "Possible to visualize cell morphology or track fluorescent biomarkers of damage",
      "Readouts - Supernatant Sampling": "Yes, measure secreted kidney injury markers (e.g. KIM-1), drug or metabolite levels in outflow",
      "Readouts - Cell Retrieval": "Feasible at endpoint, not routine in large screens",
      "Readouts - Whole Tissue": "Yes, fix tubule structure for histology if desired",
      "Readouts - TEER": "Kidney uses transport assays or barrier function readouts, may have integrated sensor for leak detection",
      "Readouts - MEA": "No",
      "Readouts - Integrated Biosensors": "Yes, nano-sensors measuring barrier or cell stress in real time",
      "Dead Volume": "Small microchannels, minimal media consumption",
      "Perfused": "Yes, continuous flow simulating fluid in tubule lumen",
      "Gas Mix Controlled": "Incubator environment",
      "Real-time Microenvironment Control": "Automated fluid flow, dosing schedules, sensor-based feedback for toxicity detection",
      "model_availability": "Internal Quris platform usage from Nortis acquisition, available via Quris’s collaborations"
    },
    {
      "Company": "Quris-AI",
      "Model": "Intestine-on-Chip (Planned)",
      "Organs/Tissues": "Human intestinal epithelium for absorption and GI safety studies",
      "Physiological/Pathological": "Healthy gut barrier, can identify GI toxicity or estimate oral bioavailability",
      "Cell Source": "iPSC-derived intestinal epithelial cells (multiple donors for genetic diversity)",
      "Multiple Cell Types": "Likely includes absorptive enterocytes + goblet cells; no immune or fibroblasts by default",
      "Stromal Cells": "No, unless co-culture added later",
      "Tissue-resident Immune": "No standard inclusion",
      "Circulating Immune": "No",
      "Crosstalk with Other Tissues": "Might link to Quris’s other chips for overall PK in future; or integrated via AI",
      "Air–Liquid Interface": "Unclear if partially used, possibly fully fluid approach in microfluidic format",
      "Extracellular Matrix": "Yes, supportive hydrogel or coated membrane for epithelial cell growth",
      "3D Scaffold": "2D monolayer or 3D micro-lumens in chip, details not yet disclosed",
      "Notable Features": "Under development, extends Quris coverage to oral absorption & GI safety, high-throughput sensor-based approach",
      "Plate/Format (Throughput)": "Likely microfluidic array, scalable to many donors/conditions",
      "Max Culture Duration": "Likely days to 2 weeks, enough for barrier formation & repeated dosing",
      "Readouts - Live Imaging": "Potential but main is sensor data for barrier integrity, cell viability",
      "Readouts - Supernatant Sampling": "Yes, apical/basolateral compartments for absorption measurement",
      "Readouts - Cell Retrieval": "Possible after experiments",
      "Readouts - Whole Tissue": "Yes, for end-of-run histology or IF",
      "Readouts - TEER": "Likely integrated to measure barrier function if akin to their BBB approach",
      "Readouts - MEA": "No",
      "Readouts - Integrated Biosensors": "Yes, consistent with Quris’s overall approach",
      "Dead Volume": "Low microfluidic volumes",
      "Perfused": "Likely partially or fully perfused microchannels simulating intestinal flow",
      "Gas Mix Controlled": "Standard incubator for now",
      "Real-time Microenvironment Control": "Automated dosing, sensor tracking. Still in R&D phase",
      "model_availability": "Future model in Quris pipeline, not fully released"
  }
]

